Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 6 To 10

Phase 3 Terminated 9 enrolled Eisai Inc. Pfizer · collab

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine the efficacy and safety of donepezil hydrochloride (Aricept) in the treatment of cognitive dysfunction shown by children with Down syndrome, aged 6 to 10 years.

Timeline

Start: 2008-09
Primary completion: 2008-10
Completion: 2008-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Donepezil	Small molecule	5 mg	Oral

Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 6 To 10

Summary

Timeline

Drugs

Indications